Skip to main content

Closed

CAI: Caris Life Sciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+34.7% / yr

Operating margin15.9%

ROIC14.1%

Financially safe

Adequate

Debt / equity0.73×

Interest coverage2.5×

Current ratio7.05×

Caris Life Sciences, Inc.

CAINASDAQ Global Select·USD·Closed

Caris Life Sciences, Inc.

CAINASDAQ·USD·Closed

$15.67

−2.61%

$15.67

−$0.42 (2.61%)

52W Range

5thpctl

Volume

1.08×avg

Mkt Cap

4.43BUSD

P/E

-10.0TTM

Div Yield

–ann

52W Range

5thpctl

Volume

1.08×avg

Market Cap

4.43BUSD

P/E Ratio

-10.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings